Aptevo Therapeutics Stock Quote APVO - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.3394

Bid

0.3225

Ask

0.35

Volume

2,533,721

0.3247 Day's Range 0.379

0.2848 52 Week Range 971.5156

Market Cap

3.197M

Previous Close

0.3604

Open

0.359

Last Trade

1000

0.3394

(formt)

Last Trade Time

Financial Volume

$ 901,750

VWAP

0.3559

Average Volume (3m)

3,341,828

Shares Outstanding

9,420,489

Dividend Yield

PE Ratio

-0.19

Earnings Per Share (EPS)

-1.85

Revenue

Net Profit

-17.41M

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aptevotherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

Aptevo Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker APVO. The last closing price for Aptevo Therapeutics was $0.36. Over the last year, Aptevo Therapeutics shares have traded in a share price range of $ 0.2848 to $ 971.5156.

Aptevo Therapeutics currently has 9,420,489 shares outstanding. The market capitalization of Aptevo Therapeutics is $3.40 million. Aptevo Therapeutics has a price to earnings ratio (PE ratio) of -0.19.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.1006	-22.8636363636	0.44	0.472	0.32	139192	0.37702667	CS
4	-0.1856	-35.3523809524	0.525	0.6559	0.2848	6427950	0.55754566	CS
12	-3.9806	-92.1435185185	4.32	5.659	0.2848	3341828	0.6427673	CS
26	-16.8206	-98.0221445221	17.16	21.56	0.2848	1924920	1.84875403	CS
52	-756.0206	-99.9551271881	756.36	971.5156	0.2848	1062410	206.94833468	CS
156	-28.9206	-98.8400546822	29.26	2640	0.2848	836283	283.62392762	CS
260	0	0	0	0.47	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NOVVUNova Vision Acquisition Corporation	$ 41.00 (207.35%)	17.4k
NOVVNova Vision Acquisition Corporation	$ 37.0001 (200.08%)	205.22k
SMXSMX Security Matters Public Company	$ 5.85 (138.78%)	50.1M
OMICSingular Genomics Systems Inc	$ 12.38 (119.12%)	2.87M
TILInstill Bio Inc	$ 84.75 (82.41%)	3.91M
GSIWGarden Stage Ltd	$ 2.9693 (-75.66%)	4.24M
UPCUniverse Pharmaceuticals Inc	$ 0.55 (-67.07%)	30.45M
VMARVision Marine Technologies Inc	$ 0.77 (-48.67%)	34.54M
PRLDPrelude Therapeutics Inc	$ 2.775 (-42.55%)	2.49M
CNEYCN Energy Group Inc	$ 0.4335 (-37.17%)	5.06M
NVDANVIDIA Corporation	$ 119.10 (-0.03%)	225.83M
XXII22nd Century Group Inc	$ 0.3447 (28.00%)	168.56M
IMRXImmuneering Corporation	$ 2.02 (41.26%)	131.85M
SQQQProShares UltraPro Short QQQ	$ 8.17 (-1.33%)	122.46M
MULNMullen Automotive Inc	$ 0.1328 (-20.48%)	119.52M